Related Experiment Video
Updated: Jun 28, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Mechanisms of resistance to alkylating agents
1Department of Oncology, Instituto di Ricerche Farmacologiche 'Mario Negri', Via Eritrea 62, 20157, Milan, Italy., deponcol@irfmn.mnegri.it.
Abstract:
Alkylating agents are the most widely used anticancer drugs whose main target is the DNA, although how exactly the DNA lesions cause cell death is still not clear. The emergence of resistance to this class of drugs as well as to other antitumor agents is one of the major causes of failure of cancer treatment. This paper reviews some of the best characterized mechanisms of resistance to alkylating agents. Pre- and post-target mechanisms are recognized, the former able to limit the formation of lethal DNA adducts, and the latter enabling the cell to repair or tolerate the damage. The role in the pre-target mechanisms of reduced drug accumulation and the increased detoxification or activation systems (such as DT-diaphorase, metallothionein, GST/GSH system, etc...) are discussed. In the post-target mechanisms the different DNA repair pathways, tolerance to alkylation damage and the 'downstream' effects (cell cycle arrest and/or apoptosis) are examined.
Insights
Alkylating agents target DNA in cancer treatment, but resistance limits efficacy. This review details how cells evade these drugs through pre-target (drug inactivation) and post-target (DNA repair) mechanisms.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Alkylating agents are crucial anticancer drugs targeting DNA.
- Drug resistance is a major obstacle in cancer chemotherapy.
- The precise mechanisms of DNA lesion-induced cell death remain unclear.
Purpose of the Study:
- To review characterized mechanisms of resistance to alkylating agents.
- To differentiate between pre- and post-target resistance strategies.
- To discuss the role of cellular systems in modulating drug efficacy.
Main Methods:
- Literature review of established resistance mechanisms.
- Categorization of resistance into pre- and post-target pathways.
- Examination of specific cellular components involved in resistance.
Main Results:
- Pre-target mechanisms limit DNA adduct formation via reduced drug uptake or enhanced detoxification (e.g., DT-diaphorase, metallothionein, GST/GSH).
- Post-target mechanisms involve DNA repair pathways, damage tolerance, and downstream effects like cell cycle arrest and apoptosis.
- Various cellular systems contribute to resistance against alkylating agents.
Conclusions:
- Understanding resistance mechanisms is vital for improving cancer treatment outcomes.
- Both limiting drug-target interaction and enhancing cellular repair/tolerance are key resistance strategies.
- Further research into these mechanisms can guide the development of more effective therapies.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Base Excision Repair
The first step of...
Inhibitors of Bacterial DNA Synthesis
Overview of DNA Repair
Chemically...

